[ad_1]
Greek neuroscientist Menelaos Pangalos spoke about the effectiveness of the vaccine and said that he will do it himself when it is his turn.
The belief that the AstraZeneca vaccine it will also be effective for your new executives coronavirus, expressed speaking with the ERT correspondent in London Eudoxia Liberi, the Executive Vice President of Research and Development of the company, Menelaos Pangalos. Revealed that vaccine provide protection for at least 12 months and he appealed to the world to get vaccinated.
In the interview broadcast by ERT1 main newsletter on New Years Eve, the Greek neuroscientist with Chios originWhen asked if the vaccine would be effective in the new strains of the virus, he said: “We think it will be, but eventually we will have to create the data and that data will be created in the coming days and weeks.” “Our work in structural biology suggests that at least in the new variant in the UK our vaccine will be effective, but we obviously want to create the data to confirm our belief that it will remain effective.”
Mr. Pangalos seemed to understand the reluctance of a part of the world to vaccinate. “But I have to mention here the rigor with which these vaccines have been studied in tens of thousands of people and the rigor on the part of regulators to see all the data and work very quickly,” he said. that there is no difference with any other vaccine that has been developed or with any other drug. “So I think people should have confidence in the regulatory authorities and the vaccines that have been approved in their countries.”
He made no secret that he would urge his family to get any available vaccines. if it belongs to Pfizer or Moderna or any other approved vaccine. He has not been vaccinated yet, but as he said, he is waiting his turn and will do so as soon as possible. “I’ll do it when it’s available to me.” I’m looking forward to it, “he said.
The vaccine protects for at least 12 months.
Asked about how long the virus vaccine will last, He clarified that we must watch it for a period of time. But since, as he explained, the level of immunity after the second dose, said he has reasonable hopes that “Iwe have protection for at least 12 months, we expect more. “
The Greek neuroscientist stressed that protection against coronavirus starts three weeks after the first dose. “What we have now approved in our company is that the first installment is made and then you are protected, we wait 21 days after the first installment. We have verified that the protection is around 70%. No one is seriously ill or has been in the hospital. So far there are no such data. You can then take the second dose between the fourth and twelfth weeks, anytime between the fourth and twelfth weeks, and the protection from this second dose is also about 70%. Again, no one has gone to the hospital or is seriously ill after the second dose. In general, until now, the effectiveness after the first and second doses is of the order of 70% and the protection begins 21 days after receiving the first dose in vaccinated people. The closer you get between the eighth and the twelfth week, the more effective it will be and there is evidence in the vaccine identification that the longer we wait, the better the immune response. “Therefore, we believe that when we reach this ‘sweet spot’ between the eighth and the twelfth week, we expect the effectiveness to increase,” he concluded.
Surprise by the decision of the European Medicines Agency
Referring to advantages of the AstraZeneca vaccine reported to be relatively inexpensive, stored in the refrigerator at 4 degrees Celsius, and easy to use. Asked why European Medicines Agency Mr. Pangalos did not approve the vaccine. expressed surprise. He explained that AstraZeneca provided the European Medicines Agency with the same information as the UK Regulatory Authority and other regulators around the world. “We submitted the documentation for our conditional mark in the application on December 24, we answered all the questions that were sent to us and we look forward to continuing to cooperate with the EOF” to approve this vaccine in Europe as soon as possible, “he said.
Regarding his plans for the future, Mr. Pangalos did not hide what he expected gladly return to Greece because he has to see his mother who has been in Chios, but also his relatives for more than a year. Finally, he expressed the hope that a cure will be found so that everyone, around the world, “will soon return to a more normal life.”
